These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36113946)

  • 1. Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for people with HIV who use drugs: study protocol for a mixed-methods, multisite, observational study.
    Kay ES; Creasy S; Batey DS; Coulter R; Egan JE; Fisk S; Friedman MR; Kinsky S; Krier S; Noble V; Turan B; Turan JM; Yu L; Hawk M
    BMJ Open; 2022 Sep; 12(9):e067219. PubMed ID: 36113946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Qualitative Exploration of Providers' Approaches to Relational Harm Reduction in HIV Primary Care Settings.
    Kay ES; Creasy S; Townsend J; Hawk M
    Res Sq; 2024 Mar; ():. PubMed ID: 38586007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan.
    Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N
    Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative exploration of health care workers' approaches to relational harm reduction in HIV primary care settings.
    Kay ES; Creasy SL; Townsend J; Hawk M
    Harm Reduct J; 2024 May; 21(1):97. PubMed ID: 38760824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Transgender Education for Affirmative and Competent HIV and Healthcare (TEACHH)': protocol of community-based intervention development and a non-randomised multisite pilot study with pre-post test design in Canada.
    Lacombe-Duncan A; Logie CH; Persad Y; Leblanc G; Nation K; Kia H; Scheim AI; Lyons T; Loutfy M
    BMJ Open; 2020 Jul; 10(7):e034144. PubMed ID: 32737085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intersectional stigma and the non-communicable disease syndemic in the context of HIV: protocol for a multisite, observational study in the USA.
    Friedman MR; Badri S; Bowleg L; Haberlen SA; Jones DL; Kempf MC; Konkle-Parker D; Kwait J; Martinson J; Mimiaga MJ; Plankey MW; Stosor V; Tsai AC; Turan JM; Ware D; Wu K
    BMJ Open; 2024 Apr; 14(4):e075368. PubMed ID: 38670612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Montréal's harm reduction interventions for people who inject drugs: protocol for observational study and cost-effectiveness analysis.
    Panagiotoglou D; Abrahamowicz M; Buckeridge DL; Caro JJ; Latimer E; Maheu-Giroux M; Strumpf EC
    BMJ Open; 2021 Oct; 11(10):e053191. PubMed ID: 34702731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and structural barriers and facilitators to HIV healthcare and harm reduction services for people experiencing syndemics in Manitoba: study protocol.
    Rueda ZV; Haworth-Brockman M; Sobie C; Villacis E; Larcombe L; Maier K; Deering K; Sanguins J; Templeton K; MacKenzie L; Ireland L; Kasper K; Payne M; Bullard J; Krusi A; Pick N; Myran T; Meyers A; Keynan Y
    BMJ Open; 2023 Aug; 13(8):e067813. PubMed ID: 37532474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural Appalachia.
    Young AM; Havens JR; Cooper HLF; Fallin-Bennett A; Fanucchi L; Freeman PR; Knudsen H; Livingston MD; McCollister KE; Stone J; Vickerman P; Freeman E; Jahangir T; Larimore E; White CR; Cheatom C; Community Staff K; Design Team K
    BMJ Open; 2024 Mar; 14(3):e083983. PubMed ID: 38431295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
    Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
    AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City.
    Fong C; Mateu-Gelabert P; Ciervo C; Eckhardt B; Aponte-Melendez Y; Kapadia S; Marks K
    Drug Alcohol Depend; 2021 Apr; 221():108589. PubMed ID: 33621804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stigma experienced by people living with HIV who are on methadone maintenance treatment and have symptoms of common mental disorders in Hanoi, Vietnam: a qualitative study.
    Tran HV; Filipowicz TR; Landrum KR; Nong HTT; Tran TTT; Pence BW; Go VF; Le GM; Nguyen MX; Verhey R; Chibanda D; Ho HT; Gaynes BN
    AIDS Res Ther; 2022 Dec; 19(1):63. PubMed ID: 36517849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of Intersectional HIV and Substance Use Stigma Affecting People with HIV and Substance Use in St. Petersburg, Russia.
    Lodi S; Rossi SL; Bendiks S; Gnatienko N; Lloyd-Travaglini C; Vetrova M; Toussova O; Bushara N; Blokhina E; Krupitsky E; Ekstrand ML; Lioznov D; Samet JH; Lunze K
    AIDS Behav; 2023 Feb; 27(2):462-472. PubMed ID: 35916947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs.
    Tookes HE; Bartholomew TS; Suarez E; Ekowo E; Ginoza M; Forrest DW; Serota DP; Rodriguez A; Kolber MA; Feaster DJ; Mooss A; Boyd D; Sternberg C; Metsch LR
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109124. PubMed ID: 34781096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
    Mburu G; Ayon S; Tsai AC; Ndimbii J; Wang B; Strathdee S; Seeley J
    Harm Reduct J; 2018 May; 15(1):29. PubMed ID: 29801494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peer driven or driven peers? A rapid review of peer involvement of people who use drugs in HIV and harm reduction services in low- and middle-income countries.
    Chang J; Shelly S; Busz M; Stoicescu C; Iryawan AR; Madybaeva D; de Boer Y; Guise A
    Harm Reduct J; 2021 Feb; 18(1):15. PubMed ID: 33536033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and Provider Perspectives on HIV Stigma in Healthcare Settings in Underserved Areas of the US South: A Mixed Methods Study.
    Crockett KB; Turan B; Whitfield S; Kay ES; Budhwani H; Fifolt M; Hauenstein K; Ladner MD; Sewell J; Payne-Foster P; Nyblade L; Batey DS; Turan JM
    AIDS Behav; 2022 Jan; 26(Suppl 1):112-124. PubMed ID: 34581951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing Stigma Toward People Who Inject Drugs: Harm Reduction Training for First-Year Medical Students.
    Avra T; Cowan A; Friedman J; Fukushima J; Nelson A; Truman K; Stevens A; Bourgois P; Hansen H; Shover C; Goodman-Meza D
    Acad Med; 2024 Jun; 99(6):613-617. PubMed ID: 38412474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.